Pancreatic polypeptide-producing tumors. Report on two cases.

Area of Science:

• Endocrinology
• Oncology
• Gastroenterology

Background:

• Malignant endocrine pancreatic tumors are rare and can exhibit diverse clinical presentations.
• Understanding the specific hormone production of these tumors is crucial for diagnosis and treatment.

Observation:

• Two cases of malignant endocrine pancreatic tumors were analyzed for their histochemical, chemical, and clinical features.
• Both tumors demonstrated pancreatic polypeptide (PP)-immunoreactivity in most tumor cells.
• One tumor also contained serotonin-producing cells, while the other had gastrin-producing cells.

Findings:

• Both tumors were confirmed to hypersecrete pancreatic polypeptide (PP).
• One tumor produced serotonin, and the other produced gastrin.
• While no PP-associated symptoms were observed, hypergastrinemia in one patient may have contributed to a bleeding duodenal ulcer.
• Despite high malignancy, clinical courses varied significantly, with one patient surviving 2 years post-diagnosis.

Implications:

• This study highlights the variable clinical impact of hormone secretion from malignant endocrine pancreatic tumors.
• It underscores the importance of identifying specific hormone profiles for accurate prognosis and management.
• Further research into the distinct clinical trajectories associated with different hormone-secreting pancreatic tumors is warranted.